ARTICLE | Company News
Applied Molecular, Biosynexus deal
January 2, 2001 8:00 AM UTC
AMEV will use its directed evolution technology to optimize Biosynexus's antibody to prevent staphylococcus bacterial infections in neonatal and pediatric patients. AMEV will receive research funding,...